Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial

Diabetes Care. 2006 Aug;29(8):1918-20. doi: 10.2337/dc05-2495.
No abstract available

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Carbamates / adverse effects
  • Carbamates / therapeutic use*
  • Cross-Over Studies
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glyburide / adverse effects
  • Glyburide / therapeutic use*
  • Humans
  • Piperidines / adverse effects
  • Piperidines / therapeutic use*

Substances

  • Carbamates
  • Piperidines
  • repaglinide
  • Glyburide